Related references
Note: Only part of the references are listed.High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells
Yuexin Zhou et al.
NATURE (2014)
Bidirectional effect of Wnt signaling antagonist DKK1 on the modulation of anthrax toxin uptake
Qian LiLi et al.
SCIENCE CHINA-LIFE SCIENCES (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
Maria Teresa Catanese et al.
JOURNAL OF VIROLOGY (2013)
The ins and outs of hepatitis C virus entry and assembly
Brett D. Lindenbach et al.
NATURE REVIEWS MICROBIOLOGY (2013)
A Novel Monoclonal Anti-CD81 Antibody Produced by Genetic Immunization Efficiently Inhibits Hepatitis C Virus Cell-Cell Transmission
Isabel Fofana et al.
PLOS ONE (2013)
ULtiMATE System for Rapid Assembly of Customized TAL Effectors
Junjiao Yang et al.
PLOS ONE (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor
Samuel James Matthews et al.
CLINICAL THERAPEUTICS (2012)
HCV Infection by Cell-to-Cell Transmission: Choice or Necessity?
G. Carloni et al.
CURRENT MOLECULAR MEDICINE (2012)
Cell Culture-Adaptive Mutations Promote Viral Protein-Protein Interactions and Morphogenesis of Infectious Hepatitis C Virus
Jieyun Jiang et al.
JOURNAL OF VIROLOGY (2012)
Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor
Bruno Sainz et al.
NATURE MEDICINE (2012)
Hepatitis C virus entry into hepatocytes: Molecular mechanisms and targets for antiviral therapies
Mirjam B. Zeisel et al.
JOURNAL OF HEPATOLOGY (2011)
Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
Claire L. Brimacombe et al.
JOURNAL OF VIROLOGY (2011)
A TALE nuclease architecture for efficient genome editing
Jeffrey C. Miller et al.
NATURE BIOTECHNOLOGY (2011)
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Joachim Lupberger et al.
NATURE MEDICINE (2011)
A cell-based reporter assay for inhibitor screening of hepatitis C virus RNA-dependent RNA polymerase
Jin-Ching Lee et al.
ANALYTICAL BIOCHEMISTRY (2010)
Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
Christopher T. Jones et al.
NATURE BIOTECHNOLOGY (2010)
Establishment of an indicator cell system for hepatitis C virus
Yoshinori Tanaka et al.
MICROBIOLOGY AND IMMUNOLOGY (2010)
A cell protection screen reveals potent inhibitors of multiple stages of the hepatitis C virus life cycle
Karuppiah Chockalingam et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Development of NS3/4A Protease-Based Reporter Assay Suitable for Efficiently Assessing Hepatitis C Virus Infection
Kao-Lu Pan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
A Functional Genomic Screen Identifies Cellular Cofactors of Hepatitis C Virus Replication
Andrew W. Tai et al.
CELL HOST & MICROBE (2009)
CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells
Jeroen Witteveldt et al.
JOURNAL OF GENERAL VIROLOGY (2009)
Human occludin is a hepatitis C virus entry factor required for infection of mouse cells
Alexander Ploss et al.
NATURE (2009)
MAVS-Mediated Apoptosis and Its Inhibition by Viral Proteins
Yu Lei et al.
PLOS ONE (2009)
Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus
Qingxia Han et al.
VIRUS RESEARCH (2009)
Monitoring the antiviral effect of alpha interferon on individual cells
Chon Saeng Kim et al.
JOURNAL OF VIROLOGY (2007)
Replication of hepatitis C virus
Darius Moradpour et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes
Torsten Schaller et al.
JOURNAL OF VIROLOGY (2007)
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Matthew J. Evans et al.
NATURE (2007)
A hepatitis C virus (HCV) NS3/4A protease-dependent strategy for the identification and purification of HCV-infected cells
Adrien Breiman et al.
JOURNAL OF GENERAL VIROLOGY (2006)
A single lentiviral vector platform for microRNA-based conditional RNA interference and coordinated transgene expression
Kum-Joo Shin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses
George Koutsoudakis et al.
JOURNAL OF VIROLOGY (2006)
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity
XD Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
E Meylan et al.
NATURE (2005)
High-throughput cell-based screening for hepatitis C virus NS3/4A protease inhibitors
JC Lee et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2005)
Complete replication of hepatitis C virus in cell culture
BD Lindenbach et al.
SCIENCE (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Comparison of single regulated lentiviral vectors with rtTA expression driven by an autoregulatory loop or a constitutive promoter
D Markusic et al.
NUCLEIC ACIDS RESEARCH (2005)
Viral evolution as a tool to improve the tetracycline-regulated gene expression system
AT Das et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Modified apoptotic molecule (BID) reduces hepatitis C virus infection in mice with chimeric human livers
EC Hsu et al.
NATURE BIOTECHNOLOGY (2003)
Genomic analysis of the host response to hepatitis C virus infection
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
E Scarselli et al.
EMBO JOURNAL (2002)
Share Paper
